Cancers, Vol. 16, Pages 1393: Dexamethasone in Patients with Glioblastoma: A Systematic Review and Meta-Analysis

Conclusion: Despite the widespread use of dexamethasone in glioblastoma patients, its use is correlated with worse long-term outcomes. Consequently, Dexamethasone administration should be restricted to selected symptomatic patients. Future prospective studies are crucial to confirm these findings.

Source: Cancers - April 1, 2024 Category: Cancer & Oncology Authors: Pierre Scheffler Christian Fung Shahan Momjian Dominik Koessinger Levin H äni Nicolas Neidert Jakob Straehle Florian Volz Oliver Schnell J ürgen Beck Amir El Rahal Tags: Systematic Review Source Type: research